Mechanisms of Disease: Role of purinergic signaling in the pathophysiology of bladder dysfunction

Nature Clinical Practice Urology

Volumn 3, Issue 4, 2006, Pages 206-215

  Ruggieri Sr , Michael R ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ATP; Bladder; Bladder diseases; Neurogenic bladder dysfunction; Purinergic receptors

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 2',3' O (2,4,6 TRINITROPHENYL)ADENOSINE 5' TRIPHOSPHATE; [8,8' [CARBONYL BIS(IMINO 3,1 PHENYLENECARBONYLAMINO)] BIS (1,3,5, NAPHTHALENETRISULFONIC ACID); A 317491; ADENOSINE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; CAPSAICIN; DIINOSINE PENTAPHOSPHATE; DOXAZOSIN; G PROTEIN COUPLED RECEPTOR; HEPARIN; ION CHANNEL; N [1 [4 (5 ISOQUINOLINESULFONYL) ALPHA METHYLBENZYL] 2 (4 PHENYL 1 PIPERAZINYL)ETHYL] 5 ISOQUINOLINESULFONAMIDE; N [1 [N METHYL 4 (5 ISOQUINOLINESULFONYL)BENZYL] 2 (4 PHENYLPIPERAZINE)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NEUROTRANSMITTER; NF 023; NF 449; PURINE NUCLEOSIDE; PURINE NUCLEOTIDE; PURINE P2X RECEPTOR; PURINE P2X1 RECEPTOR; PURINE P2X2 RECEPTOR; PURINE P2X3 RECEPTOR; PURINE P2X4 RECEPTOR; PURINE P2X5 RECEPTOR; PURINE P2Y RECEPTOR; PURINE RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SURAMIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACETYLCHOLINE RELEASE; BLADDER CONTRACTION; BLADDER DYSFUNCTION; BLADDER INNERVATION; CHANNEL GATING; DETRUSOR DYSSYNERGIA; DETRUSOR MUSCLE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG PENETRATION; DRUG SCREENING; DRUG SELECTIVITY; HUMAN; HYPERALGESIA; INTERSTITIAL CYSTITIS; MOLECULAR CLONING; NONHUMAN; PATHOPHYSIOLOGY; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR BLOCKING; REVIEW; SENSORY NERVE CELL; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; URGE INCONTINENCE; UROTHELIUM;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; BENZENESULFONATES; HUMANS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PHENOLS; POLYCYCLIC COMPOUNDS; RECEPTORS, PURINERGIC; SIGNAL TRANSDUCTION; URINARY BLADDER;

EID: 33645782234     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro0456     Document Type: Review

References (62)

1. Abrams P et al. (2003) The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Urology 61: 37-49
2. Cowan WD and Daniel EE (1983) Human female bladder and its noncholinergic contractile function. Can J Physiol Pharmacol 61: 1236-1246
3. Dean DM and Downie JW (1978) Contribution of adrenergic and "purinergic" neurotransmission to contraction in rabbit detrusor. J Pharmacol Exp Ther 207: 431-445
4. Burnstock G (2001) Purinergic signalling in lower urinary tract. In Handbook of Experimental Pharmacology, 423-515 (Eds Abbracchio MP and Williams M) Berlin: Springer-Verlag
5. Levin RM et al. (1986) Functional effects of the purinergic innervation of the rabbit urinary bladder. J Pharmacol Exp Ther 236: 452-457
6. Ruggieri MR et al. (1990) Bladder purinergic receptors. J Urol 144: 176-181
7. Bayliss M et al. (1999) A quantitative study of atropine-resistant contractile responses in human detrusor smooth muscle, from stable, unstable and obstructed bladders. J Urol 162: 1833-1839
8. Husted S et al. (1983) Direct effects of adenosine and adenine nucleotides on isolated human urinary bladder and their influence on electrically induced contractions. J Urol 130: 392-398
9. Sjogren C et al. (1982) Atropine resistance of transmurally stimulated isolated human bladder muscle. J Urol 128: 1368-1371
10. Palea S et al. (1993) Evidence for purinergic neurotransmission in human urinary bladder affected by interstitial cystitis. J Urol 150: 2007-2012
11. Yoshida M et al. (2001) Age-related changes in cholinergic and purinergic neurotransmission in human isolated bladder smooth muscles. Exp Gerontol 36: 99-109
12. Birder LA et al. (2003) Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium. Am J Physiol Renal Physiol 285: F423-429
13. Birder LA et al. (2004) Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am J Physiol Renal Physiol 287: F1084-1091
14. Birder LA (2005) More than just a barrier: Urothelium as a drug target for uriary bladder pain. Am J Physiol 289: F489-495
15. 3 knock-out mice reveal a major sensory role for urothelially released ATP. J Neurosci 21: 5670-5677
16. 3-deficient mice. Nature 407: 1011-1015
17. Inoue R and Brading AF (1991) Human, pig and guinea-pig bladder smooth muscle cells generate similar inward currents in response to purinoceptor activation. Br J Pharmacol 103: 1840-1841
18. Harvey RA et al. (2002) The contractile potency of adenosine triphosphate and ecto-adenosine triphosphatase activity in guinea pig detrusor and detrusor from patients with a stable, unstable or obstructed bladder. J Urology 168: 1235-1239
19. Rocha I et al. (2001) Effect on urinary bladder function and arterial blood pressure of the activation of putative purine receptors in brainstem areas. Auton Neurosci 88: 6-15
20. Drury AN and Szent-Gyorgyi A (1929) The physiological activity of adenine compounds with special reference to their actions upon the mammalian heart. J Physiol (Lond) 68: 213-237
21. Burnstock G (1978) A basis for distinguishing two types of purinergic receptor. In Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach 107-118 (Eds Straub RW and Bolis L) New York: Raven Press
22. Fredholm BB et al. (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53: 527-552
23. Burnstock G and Kennedy C (1985) Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 16: 433-440
24. Burnstock G (2004) Introduction: P2 receptors. Curr Top Med Chem 4: 793-803
25. Burnstock G (2002) Potential therapeutic targets in the rapidly expanding field of purinergic signalling. Clin Med 2: 45-53
26. + channels in guinea pig urinary bladder smooth muscle. J Pharmacol Exp Ther 300: 910-917
27. Volpini R et al. (2003) Medicinal chemistry and pharmacology of A2B adenosine receptors. Curr Top Med Chem 3: 427-443
28. Rubinstein R et al. (1998) Effect of exogenous adenosine and its monophosphate on the contractile response to acetylcholine in the human isolated detrusor muscle strips. J Auton Pharmacol 18: 99-104
29. Fry CH et al. (2004) Control of bladder function by peripheral nerves: avenues for novel drug targets. Urology 63: 24-31
30. de Groat WC (2004) The urothelium in overactive bladder: Passive bystander or active participant? Urology 64: 7-11
31. Sui GP et al. (2004) Electrical characteristics of suburothelial cells isolated from the human bladder. J Urol 171: 938-943
32. Wu C et al. (2004) Purinergic regulation of guinea pig suburothelial myofibroblasts. J Physiol 559: 231-243
33. North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82: 1013-1067
34. Unwin N (2005) Refined structure of the nicotinic acetylcholine receptor at 4A resolution. J Mol Biol 346: 967-989
35. Burnstock G et al. (1978) Direct evidence for ATP release from non-adrenergic, non-cholinergic ("purinergic") nerves in the guinea-pig taenia coli and bladder. Eur J Pharmacol 49: 145-149
36. Ferguson DR et al. (1997) ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes - a possible sensory mechanism? J Physiol 505: 503-511
37. Kumar V et al. (2004) Characteristics of adenosine triphosphatase release from porcine and human normal bladder. J Urol 172: 744-747
38. Yoshida M et al. (2004) Management of detrusor dysfunction in the elderly: Changes in acetylcholine and adenosine triphosphate release during aging. Urology 63: 17-23
39. Sun Y et al. (2001) Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis. J Urol 166: 1951-1956
40. Sun Y et al. (2001) Stretch-activated release of adenosine triphosphate by bladder uroepithelia is augmented in interstitial cystitis. Urology 57: 131
41. Sun Y and Chai TC (2002) Effects of dimethyl sulphoxide and heparin on stretch-activated ATP release by bladder urothelial cells from patients with interstitial cystitis. BJU Int 90: 381-385
42. Sun Y et al. (2002) Effect of doxazosin on stretch-activated adenosine triphosphate release in bladder urothelial cells from patients with benign prostatic hyperplasia. Urology 60: 351-356
43. Pandita RK and Andersson KE (2002) Intravesical adenosine triphosphate stimulates the micturition reflex in awake, freely moving rats. J Urol 168: 1230-1234
44. Smith CP et al. (2005) Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: Effect of botulinum toxin A. Neurochem Int 47: 291-297
45. Wang EC et al. (2005) ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells. J Clin Invest 115: 2412-2422
46. O'Reilly BA et al. (2002) P2X receptors and their role in female idiopathic detrusor instability. J Urol 167: 157-164
47. Ray FR et al. (2003) Loss of purinergic P2X receptor innervation in human detrusor and subepithelium from adults with sensory urgency. Cell Tissue Res 314: 351-359
48. Elneil S et al. (2001) Distribution of P2X(1) and P2X(3) receptors in the rat and human urinary bladder. Pharmacology 63: 120-128
49. Moore KH et al. (2001) Loss of purinergic P2X(3) and P2X(5) receptor innervation in human detrusor from adults with urge incontinence. J Neurosci 21: RC166
50. Tempest HV et al. (2004) P2X and P2X receptor expression in human bladder urothelium and changes in interstitial cystitis. BJU Int 93: 1344-1348
51. Palea S et al. (1995) Evidence for the presence of both pre- and postjunctional P2-purinoceptor subtypes in human isolated urinary bladder. Br J Pharmacol 114: 35-40
52. 3 and TRPV1 in suburothelial nerve fibers following detrusor injections of botulinum toxin for human detrusor overactivity. J Urol 174: 977-983
53. 3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin. Eur Urol 46: 247-253
54. Burnstock G (2001) Purine-mediated signalling in pain and visceral perception. Trends Pharmacol Sci 22: 182-188
55. Palea S et al. (1994) ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y. J Pharmacol Exp Ther 269: 193-197
56. 2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci USA 99: 17179-17184
57. 2/3 receptor antagonist, reverses inflammatory mechanical hyperalgesia through action at peripheral receptors in rats. Eur J Pharmacol 504: 45-53
58. 1 receptor antagonist. Neuropharmacology 48: 461-468
59. Vial C and Evans RJ (2000) P2X receptor expression in mouse urinary bladder and the requirement of P2X(1) receptors for functional P2X receptor responses in the mouse urinary bladder smooth muscle. Br J Pharmacol 131: 1489-1495
60. 3 in human urinary bladder. BJU Int 87: 774-779
61. 3 receptor during stretch of bladder urothelial cells from patients with interstitial cystitis. J Urol 171: 448-452
62. 7 subunit-like immuno reactivity in the nucleus of visceral smooth muscle cells of the guinea pig. Auton Neurosci 106: 103-109